Clinical Performance of a Novel LIAISON Fecal Calprotectin Assay for Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome.

Journal Information

Full Title: J Clin Gastroenterol

Abbreviation: J Clin Gastroenterol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"C.Z., A.M.R., and F.A.B. are employees of DiaSorin the manufacturer of the LIAISON Calprotectin test. B.P.V. has received honoraria from Abbvie and Janssen and research support from Roche, Takeda, Celgene, DiaSorin, and Crestovo within the past 5 years. J.P.C. declares that there is nothing to disclose."

Evidence found in paper:

"Supported by DiaSorin to support this clinical trial and all reagents for laboratory testing."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025